Long-term effectiveness and safety of trabecular microbypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension: Five-year outcomes
- PMID: 30851807
- DOI: 10.1016/j.jcrs.2018.10.029
Long-term effectiveness and safety of trabecular microbypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension: Five-year outcomes
Abstract
Purpose: To assess 5-year outcomes after implantation of 1 trabecular microbypass stent during cataract surgery in eyes with open-angle glaucoma (OAG) or ocular hypertension.
Setting: Private ophthalmology clinic (AaM Augenklinik am Marienplatz, Munich, Germany).
Design: Prospective nonrandomized consecutive case series.
Methods: One trabecular microbypass stent was implanted after phacoemulsification cataract surgery by one surgeon over 4 years. Evaluations included intraocular pressure (IOP), medications, corrected distance visual acuity, cup-to-disc ratio, complications, and adverse events.
Results: This case series included 65 eyes of 43 patients with OAG (including primary, n = 39; pseudoexfoliative, n = 14; secondary uveitic, n = 1; posttraumatic, n = 1) or ocular hypertension (n = 10). Thirty-eight percent of eyes had previous trabeculectomy and/or glaucoma laser procedures, and 68% were on 2 or more preoperative medications. Twenty-six eyes completed follow-up through 5 years, and follow-up is ongoing. Among eyes without additional glaucoma surgery, the mean year 5 IOP decreased by 38% to 14.7 mm Hg ± 3.0 (SD) versus 23.7 ± 7.4 mm Hg preoperatively; 92% of eyes had a mean year 5 IOP of 18 mm Hg or lower and 65% had an IOP of 15 mm Hg or lower. Medications were reduced by 75% to 0.5 ± 0.9 medications versus 2.0 ± 1.0 preoperatively, with 4% of eyes on 3 to 4 medications versus 28% preoperatively, and 69% medication-free versus 5% preoperatively. The mean IOP at all postoperative visits was 16.0 mm Hg or lower and the mean medication number was 0.5 or less. Safety was favorable throughout the follow-up.
Conclusions: In a real-life cohort of eyes with OAG or ocular hypertension, substantial, durable, and safe IOP and medication reductions were achieved through 5 years after trabecular microbypass stent implantation with cataract surgery.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: Long-term results.J Cataract Refract Surg. 2015 Dec;41(12):2664-71. doi: 10.1016/j.jcrs.2015.06.032. J Cataract Refract Surg. 2015. PMID: 26796447
-
Evaluation of a Trabecular Microbypass Stent With Cataract Extraction in Severe Primary Open-angle Glaucoma.J Glaucoma. 2018 Jan;27(1):71-76. doi: 10.1097/IJG.0000000000000825. J Glaucoma. 2018. PMID: 29194199
-
Matched Cohort Study of Cataract Surgery With and Without Trabecular Microbypass Stent Implantation in Primary Angle-Closure Glaucoma.Am J Ophthalmol. 2021 Apr;224:310-320. doi: 10.1016/j.ajo.2020.12.032. Epub 2021 Jan 9. Am J Ophthalmol. 2021. PMID: 33428885
-
Standalone iStent Trabecular Micro-bypass Glaucoma Surgery: A Systematic Review and Meta-Analysis.J Glaucoma. 2021 Jul 1;30(7):606-620. doi: 10.1097/IJG.0000000000001805. J Glaucoma. 2021. PMID: 33596009
-
Trabecular Procedures Combined with Cataract Surgery for Open-Angle Glaucoma: A Report by the American Academy of Ophthalmology.Ophthalmology. 2024 Mar;131(3):370-382. doi: 10.1016/j.ophtha.2023.10.009. Epub 2023 Dec 6. Ophthalmology. 2024. PMID: 38054909 Review.
Cited by
-
iStent inject trabecular microbypass stent implantation with cataract extraction in open-angle glaucoma: early clinical experience.Eye Vis (Lond). 2020 May 20;7:28. doi: 10.1186/s40662-020-00194-3. eCollection 2020. Eye Vis (Lond). 2020. PMID: 32490028 Free PMC article.
-
Mid-Term Evaluation of iStent Inject® Trabecular Micro-Bypass Stent Implantation with or without Phacoemulsification: A Retrospective Study.Clin Ophthalmol. 2020 Dec 16;14:4403-4413. doi: 10.2147/OPTH.S283587. eCollection 2020. Clin Ophthalmol. 2020. PMID: 33364745 Free PMC article.
-
Standalone Implantation of 2-3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma.Ophthalmol Ther. 2022 Feb;11(1):271-292. doi: 10.1007/s40123-021-00424-4. Epub 2021 Nov 25. Ophthalmol Ther. 2022. PMID: 34825352 Free PMC article.
-
Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery.Clin Ophthalmol. 2021 May 5;15:1861-1873. doi: 10.2147/OPTH.S302684. eCollection 2021. Clin Ophthalmol. 2021. PMID: 33981138 Free PMC article.
-
The Effectiveness of First-Generation iStent Microbypass Implantation Depends on Initial Intraocular Pressure: 24-Month Follow-Up-Prospective Clinical Trial.J Ophthalmol. 2020 Jun 23;2020:8164703. doi: 10.1155/2020/8164703. eCollection 2020. J Ophthalmol. 2020. PMID: 32676205 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical